Evaluation of ‘implications for research’ sections in systematic reviews of interventions in advanced cancer patients – a meta-research study

Author:

Siemens W.1,Bantle G.1,Ebner C.1,Blümle A.2,Becker G.3,Schwarzer G.2,Meerpohl J. J.1

Affiliation:

1. Medical Center - University of Freiburg, University of Freiburg

2. University of Freiburg

3. University Medical Center Freiburg, University of Freiburg

Abstract

Abstract Background Implications for research (IfR) sections are an important part of systematic reviews (SRs) in healthcare. The PRISMA 2020 statement recommends discussion of the implications of the results for practice, while Cochrane Reviews require an IfR section. However, it is unclear to what extent systematic reviews discuss IfR and if this section is useful. We aimed i) to assess whether systematic reviews include an IfR section and ii) to evaluate which elements informed reporting of IfR. Methods We conducted a meta-research study based on SRs of interventions in advanced cancer patients from a previous project (CRD42019134904). We assessed if the following predefined IfR variables were referred to in the included SRs: patients, intervention, control, outcome, study design (PICOS); Grading of Recommendations, Assessment, Development and Evaluation (GRADE) domains: risk of bias, inconsistency, indirectness, imprecision, publication bias. Data were independently extracted by three reviewers after piloting the data extraction form. Discrepancies were resolved in weekly in-depth discussions. Results We included 261 SRs. The majority evaluated a pharmacological intervention (244, 93.5%); twenty-nine were Cochrane Reviews (11.1%). Four out of five SRs included an IfR section (210, 80.5%). PICOS elements commonly addressed in IfR sections were ‘intervention’ (121, 57.6%), ‘patient‘ (113, 53.8%) and ‘study design’ (107, 51.0%). The most frequent PICOS combinations were ‘patient and intervention‘ (71, 33.8%) and ‘patient, intervention and study design‘ (34, 16.2%). GRADE domains were rarely used for informing IfR recommendations: ‘risk of bias‘ (2, 1.0%), and ‘imprecision‘ (1, 0.5%), ‘inconsistency‘ (1, 0.5%). Additional factors informing IfR recommendations were considerations on cost effectiveness (9, 4.3%), reporting standards (4, 1.9%), and individual patient data meta-analysis (4, 1.9%). Conclusion Although four out of five systematic reviews of our sample included an IfR section, these were mostly considering only selected PICOS elements and GRADE domains were used rarely to guide future research recommendations. In the absence of established reporting standards, we propose more comprehensive and structured IfR sections in SRs informed by PICOS elements and GRADE domains. We suggest further empirical and theoretical work to eventually develop guidance on what IfR elements to consider and how to report IfR in SRs of interventions.

Publisher

Research Square Platform LLC

Reference27 articles.

1. Reducing waste from incomplete or unusable reports of biomedical research;Glasziou P;The Lancet,2014

2. How to increase value and reduce waste when research priorities are set;Chalmers I;The Lancet,2014

3. Justification of research using systematic reviews continues to be inconsistent in clinical health science—A systematic review and meta-analysis of meta-research studies;Andreasen J;PLoS ONE,2022

4. Nørgaard B, Draborg E, Andreasen J, Juhl CB, Yost J, Brunnhuber K, Robinson KA, Lund H. Systematic reviews are rarely used to inform study design-a systematic review and meta-analysis. J Clin Epidemiol 2022.

5. Evidence-based research series-paper 2: using an evidence-based research approach before a new study is conducted to ensure value;Lund H;J Clin Epidemiol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3